 | • レポートコード：QYR2104Z2003 • 出版社/出版日：QYResearch / 2021年4月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、短腸症候群治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（GLP-2、成長ホルモン、グルタミン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・短腸症候群治療薬の市場動向 ・企業の競争状況、市場シェア ・短腸症候群治療薬の種類別市場規模（GLP-2、成長ホルモン、グルタミン、その他） ・短腸症候群治療薬の用途別市場規模（病院薬局、小売薬局、オンライン薬局） ・短腸症候群治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・短腸症候群治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・短腸症候群治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・短腸症候群治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・短腸症候群治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ardelyx、Emmaus Life Sciences、GLyPharma Therapeutic、Merck、Naia Pharmaceuticals、Nutrinia、OxThera、Sancilio & Company、Takeda、Zealand Pharma） ・結論 |
Market Analysis and Insights: Global Drugs for Short Bowel Syndrome Market
The global Drugs for Short Bowel Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Short Bowel Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Short Bowel Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Short Bowel Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Short Bowel Syndrome market.
Global Drugs for Short Bowel Syndrome Scope and Market Size
Drugs for Short Bowel Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Short Bowel Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
GLP-2
Growth Hormone
Glutamine
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ardelyx
Emmaus Life Sciences
GLyPharma Therapeutic
Merck
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio & Company
Takeda
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Drugs for Short Bowel Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2016-2027)
2.2 Drugs for Short Bowel Syndrome Growth Trends by Regions
2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drugs for Short Bowel Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Drugs for Short Bowel Syndrome Industry Dynamic
2.3.1 Drugs for Short Bowel Syndrome Market Trends
2.3.2 Drugs for Short Bowel Syndrome Market Drivers
2.3.3 Drugs for Short Bowel Syndrome Market Challenges
2.3.4 Drugs for Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2016-2021)
3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2020
3.5 Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Short Bowel Syndrome Breakdown Data by Type
4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2022-2027)
5 Drugs for Short Bowel Syndrome Breakdown Data by Application
5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drugs for Short Bowel Syndrome Market Size (2016-2027)
6.2 North America Drugs for Short Bowel Syndrome Market Size by Type
6.2.1 North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
6.2.2 North America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
6.2.3 North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
6.3 North America Drugs for Short Bowel Syndrome Market Size by Application
6.3.1 North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
6.3.2 North America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
6.3.3 North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
6.4 North America Drugs for Short Bowel Syndrome Market Size by Country
6.4.1 North America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
6.4.2 North America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Drugs for Short Bowel Syndrome Market Size (2016-2027)
7.2 Europe Drugs for Short Bowel Syndrome Market Size by Type
7.2.1 Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
7.3 Europe Drugs for Short Bowel Syndrome Market Size by Application
7.3.1 Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country
7.4.1 Europe Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type
8.2.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application
8.3.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region
8.4.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Short Bowel Syndrome Market Size (2016-2027)
9.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type
9.2.1 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
9.3 Latin America Drugs for Short Bowel Syndrome Market Size by Application
9.3.1 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
9.4 Latin America Drugs for Short Bowel Syndrome Market Size by Country
9.4.1 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type
10.2.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application
10.3.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country
10.4.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ardelyx
11.1.1 Ardelyx Company Details
11.1.2 Ardelyx Business Overview
11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.1.5 Ardelyx Recent Development
11.2 Emmaus Life Sciences
11.2.1 Emmaus Life Sciences Company Details
11.2.2 Emmaus Life Sciences Business Overview
11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.2.5 Emmaus Life Sciences Recent Development
11.3 GLyPharma Therapeutic
11.3.1 GLyPharma Therapeutic Company Details
11.3.2 GLyPharma Therapeutic Business Overview
11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.3.5 GLyPharma Therapeutic Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.7.5 OxThera Recent Development
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.8.5 Sancilio & Company Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2016-2021)
11.10.5 Zealand Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Other
Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Drugs for Short Bowel Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drugs for Short Bowel Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Drugs for Short Bowel Syndrome Market Share by Regions (2016-2021)
Table 10. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Drugs for Short Bowel Syndrome Market Share by Regions (2022-2027)
Table 12. Drugs for Short Bowel Syndrome Market Trends
Table 13. Drugs for Short Bowel Syndrome Market Drivers
Table 14. Drugs for Short Bowel Syndrome Market Challenges
Table 15. Drugs for Short Bowel Syndrome Market Restraints
Table 16. Global Drugs for Short Bowel Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Drugs for Short Bowel Syndrome Market Share by Players (2016-2021)
Table 18. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2020)
Table 19. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Drugs for Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Table 27. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Drugs for Short Bowel Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2016-2021)
Table 31. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 63. Ardelyx Company Details
Table 64. Ardelyx Business Overview
Table 65. Ardelyx Drugs for Short Bowel Syndrome Product
Table 66. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 67. Ardelyx Recent Development
Table 68. Emmaus Life Sciences Company Details
Table 69. Emmaus Life Sciences Business Overview
Table 70. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product
Table 71. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 72. Emmaus Life Sciences Recent Development
Table 73. GLyPharma Therapeutic Company Details
Table 74. GLyPharma Therapeutic Business Overview
Table 75. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product
Table 76. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 77. GLyPharma Therapeutic Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Drugs for Short Bowel Syndrome Product
Table 81. Merck Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Naia Pharmaceuticals Company Details
Table 84. Naia Pharmaceuticals Business Overview
Table 85. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product
Table 86. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 87. Naia Pharmaceuticals Recent Development
Table 88. Nutrinia Company Details
Table 89. Nutrinia Business Overview
Table 90. Nutrinia Drugs for Short Bowel Syndrome Product
Table 91. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 92. Nutrinia Recent Development
Table 93. OxThera Company Details
Table 94. OxThera Business Overview
Table 95. OxThera Drugs for Short Bowel Syndrome Product
Table 96. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 97. OxThera Recent Development
Table 98. Sancilio & Company Company Details
Table 99. Sancilio & Company Business Overview
Table 100. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 101. Sancilio & Company Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Drugs for Short Bowel Syndrome Product
Table 105. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 106. Takeda Recent Development
Table 107. Zealand Pharma Company Details
Table 108. Zealand Pharma Business Overview
Table 109. Zealand Pharma Drugs for Short Bowel Syndrome Product
Table 110. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2016-2021) & (US$ Million)
Table 111. Zealand Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Short Bowel Syndrome Market Share by Type: 2020 VS 2027
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Other Features
Figure 6. Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugs for Short Bowel Syndrome Report Years Considered
Figure 11. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Drugs for Short Bowel Syndrome Market Share by Regions: 2020 VS 2027
Figure 14. Global Drugs for Short Bowel Syndrome Market Share by Regions (2022-2027)
Figure 15. Global Drugs for Short Bowel Syndrome Market Share by Players in 2020
Figure 16. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2020
Figure 18. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2016-2021)
Figure 19. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2022-2027)
Figure 20. North America Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 22. North America Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 23. North America Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 24. United States Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 28. Europe Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 29. Europe Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 30. Germany Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Region (2016-2027)
Figure 40. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 48. Latin America Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 49. Latin America Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 50. Mexico Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Country (2016-2027)
Figure 56. Turkey Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Drugs for Short Bowel Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 60. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 61. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 63. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 64. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 65. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 66. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 68. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed